Emergent BioSolutions Inc.

NYSE:EBS Stock Report

Market Cap: US$132.6m

Emergent BioSolutions Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Joe Papa

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.2yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

New CEO Appointment A Clear Positive For Emergent BioSolutions

Feb 27

Emergent BioSolutions: Q3 Numbers Leave Work To Be Done

Dec 18

Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow

Nov 23

Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial

Aug 23

Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)

Aug 14

Emergent BioSolutions: Making A Big Bet On Narcan

Jul 21

An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued

Jun 22
An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued

Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?

Apr 05
Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?

Emergent Biosolutions Q4 2022 Earnings Preview

Feb 24

An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued

Feb 16
An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued

Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M

Feb 15

Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments

Dec 07

Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance

Nov 09

Emergent doses first participant in Phase 1 trial for Lassa virus vaccine

Sep 06

Emergent BioSolutions: Now Long Through Sale Of October Put Spreads

Aug 24

A Look At The Fair Value Of Emergent BioSolutions Inc. (NYSE:EBS)

Aug 13
A Look At The Fair Value Of Emergent BioSolutions Inc. (NYSE:EBS)

Additional 135M COVID-19 vaccine doses destroyed at Emergent BioSolutions Baltimore plant

Aug 12

Emergent BioSolutions misses on top and bottom lines as it swings to quarterly loss

Aug 01

Moderna 2.0: 3 Stocks To Play The Potential Monkeypox Pandemic

Jul 26

Emergent BioSolutions (NYSE:EBS) Takes On Some Risk With Its Use Of Debt

Jul 26
Emergent BioSolutions (NYSE:EBS) Takes On Some Risk With Its Use Of Debt

Kamada inks $11.4 M supply deal for chickenpox preventive antibody Varizig

Jul 06

Emergent BioSolutions: A Top Pick For The Monkeypox Outbreak

May 29

Emergent BioSolutions Inc. (NYSE:EBS) Shares Could Be 37% Below Their Intrinsic Value Estimate

May 12
Emergent BioSolutions Inc. (NYSE:EBS) Shares Could Be 37% Below Their Intrinsic Value Estimate

Emergent BioSolutions (NYSE:EBS) Has A Pretty Healthy Balance Sheet

Apr 24
Emergent BioSolutions (NYSE:EBS) Has A Pretty Healthy Balance Sheet

CEO

Joe Papa (67 yo)

less than a year

Tenure

Mr. Joseph C. Papa, Jr., also known as Joe, serves as Executive Advisor at Water Street Healthcare Partners, LLC since joining in June 13, 2023. He serves as Chairman at SparingVision SAS since March 2023....


Leadership Team

NamePositionTenureCompensationOwnership
Richard Lindahl
Executive VP6yrsUS$3.52m0.30%
$ 403.2k
Jennifer Fox
Executive VP of External Affairsless than a yearUS$2.92m0.33%
$ 441.3k
Joseph Papa
CEO & Presidentless than a yearno datano data
Robert Burrows
Vice President of Investor Relations17.8yrsno datano data
Coleen Glessner
Executive Vice President of Global Quality and Ethics & Compliance1.9yrsno data0.32%
$ 419.0k
Michelle Pepin
Senior VP & Chief Human Resource Officerless than a yearno datano data
Stephanie Duatschek
Senior VPless than a yearno datano data
Kelly Warfield
Senior VP of Science & Development1.2yrsno datano data
Paul Williams
Senior Vice President of Products Business1.2yrsno data0.048%
$ 63.2k
William Hartzel
Senior Vice President of Manufacturing & Bioservicesno datano data0.067%
$ 88.7k

1.2yrs

Average Tenure

Experienced Management: EBS's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Louis Sullivan
Independent Director17.8yrsUS$410.00k0.083%
$ 110.0k
Ronald Richard
Independent Director19.2yrsUS$412.50k0.019%
$ 24.7k
Donald DeGolyer
Independent Directorless than a yearno datano data
Keith Katkin
Independent Director1.9yrsUS$446.25k0.0055%
$ 7.3k
Marvin White
Independent Director3.4yrsUS$398.75k0.011%
$ 14.7k
Zsolt Harsanyi
Independent Non-Executive Chairman19.6yrsUS$512.50k0.053%
$ 70.9k
Kathryn Zoon
Independent Director7.3yrsUS$427.50k0.031%
$ 41.0k
Neal Fowler
Independent Directorless than a yearno datano data
Sujata Dayal
Independent Director1.7yrsUS$416.58kno data

3.4yrs

Average Tenure

61yo

Average Age

Experienced Board: EBS's board of directors are considered experienced (3.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.